Zenflow, said the FDA has approved of the Zenflow Spring Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as enlarged prostate.
The Zenflow Spring Implant and Delivery System is a first-line interventional therapy (FIT) that provides urologists and their patients with a minimally invasive option.
The Zenflow Spring Implant and Delivery System opens the urethra while preserving natural anatomy through a proprietary small spring-like implant. The Spring is an FDA-approved FIT in a range of lengths and diameters, allowing for patient personalization. It is made from a super-elastic shape-memory material and delivered in an outpatient setting using the recently FDA-cleared Zenflow Spring Scope – a single-use, flexible cystoscope.
